Fact CheckerSign in

NCT05576766Not yet recruiting

Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy

Impact of Enhanced Recovery After Surgery (ERAS) Pathway on Outcomes in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 21 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Prostate cancer ranks second among all malignances in men and has become a significant threat to men's health. Robot-assisted laparoscopic radical prostatectomy (RARP) has become a standard treatment for prostate cancer. How to improve recovery following RARP surgery is worth investigating. The enhanced recovery after surgery (ERAS) pathway involves a series of evidence-based procedures. It is aimed to reduce the systemic stress response to surgery and shorten the length of hospital stay. This randomized trial aims to investigate the impact of Enhanced Recovery After Surgery (ERAS) Pathway on early outcomes after RARP surgery.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
54 (estimated)
First submitted
12 Sept 2022
Start date
Sept 2025
Primary completion date
Nov 2026
Lead sponsor
Peking University First Hospital
NCT number
NCT05576766

What you commit to

  • Study type: Interventional
  • Planned participants: 54
  • From Sept 2025 to the primary completion date, Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Scheduled to undergo combined surgery, including RARP combined with pelvic lymph node dissection or other procedures.

Other illness

  • Inability to receive preoperative aerobic exercise because of severe cardiovascular disease, motor system diseases (arthritis, lumbar vertebrae disease), or central nervous system diseases (epilepsy, parkinsonism).
  • Inability to communicate in the preoperative period because of profound dementia, deafness, or language barriers.
  • History of schizophrenia, anxiety or depressive disorders, or other mental disorders.

Other

  • American Society of Anesthesiologists (ASA) physical classification ≥IV.

Who the study is looking for

  • Aged 60 years or over but below 90 years.
  • Scheduled to undergo robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer.
  • Agree to participate in this study and give written informed consent.

Age in the registry: 60 years to 90 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Anesthesiology and Critical Care Medicine, Peking University First Hospital
Coordinator of this site? Confirm its status
BeijingChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.